CHINA RESOURCES PHARMACEUTICAL GROUP
China Resources Pharmaceutical Group operates as a pharmaceutical company. The Company researches, develops, manufactures, and distributes Chinese, western, and other medicines and health foods. China Resources Pharmaceutical serves customers throughout China.
CHINA RESOURCES PHARMACEUTICAL GROUP
Industry:
Health Care Manufacturing Pharmaceutical
Founded:
2007-01-01
Status:
Active
Contact:
852-25938991
Email Addresses:
[email protected]
Total Funding:
0
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Domain Not Resolving Mobile Non Scaleable Content Microsoft Azure DNS DigiCert SSL GeoTrust SSL Baidu Analytics
Current Employees Featured
Investors List
Cowin Capital
Cowin Capital investment in Series A - China Resources Pharmaceutical Group
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-12-10 | Denovo Biopharma | China Resources Pharmaceutical Group investment in Series D - Denovo Biopharma | 300 M CNY |
| 2019-12-12 | Pisofttech | China Resources Pharmaceutical Group investment in Series A - Pisofttech | N/A |
| 2019-07-18 | Int'l Group | China Resources Pharmaceutical Group investment in Post-IPO Equity - Int'l Group | 93.44 M CNY |
More informations about "China Resources Pharmaceutical Group"
CR Pharmaceutical
China Resources Pharmaceutical Group Limited (CR Pharmaceutical) (Stock Code: 03320.HK) is a leading integrated pharmaceutical company in China, one of the Top Three companies in the industry specializing in R&D, manufacturing, distribution, and retail of medicines and …See details»
Welcome to CRC
China Resources (Holdings) Co., Ltd. (“CR” or “China Resources Group”) is a diversified holding company registered in Hong Kong. CR was first established as “Liow & Co.” in Hong Kong in 1938, and was later restructured and renamed …See details»
China Resources Pharmaceutical Group - Crunchbase
China Resources Pharmaceutical Group operates as a pharmaceutical company. The Company researches, develops, manufactures, and distributes Chinese, …See details»
3320.HK - | Stock Price & Latest News | Reuters
5 days ago Get China Resources Pharmaceutical Group Ltd (3320.HK) real-time stock quotes, news, price and financial information from Reuters to inform your trading and investmentsSee details»
Company China Resources Pharmaceutical Group Limited
May 31, 2016 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally …See details»
China Resources Pharmaceutical Group | Company Overview
China Resources Pharmaceutical Group Ltd. is an investment holding, which engages in the research and development, manufacture, distribution, and retail of pharmaceutical and …See details»
China Resources Pharmaceutical Group Ltd - FT.com
5 days ago Year on year China Resources Pharmaceutical Group Ltd grew revenues 12.16% from 218.18bn to 244.70bn while net income improved 10.11% from 3.50bn to 3.85bn. View all …See details»
China Resources Pharmaceutical Group | Supply Chain Magazine
China Resources Pharmaceutical Group Company Facts. HQ Location. Beijing, China. Employee Count. 73,000. CEO. Xu Jianguo. Revenue. $9.5 billion USD. Company Profile. CR …See details»
China Resources Pharmaceutical Group Is the Third-Largest …
Apr 11, 2024 The revenue of China Resources Pharmaceutical Group grew at a compounded annual growth rate of 10.4% over the past 10 years. The growth is driven by its medical …See details»
China Resources Pharmaceutical Group Ltd - Financial Times
Nov 19, 2024 CHINA RESOURCES PHARMACEUTICAL GROUP LIMITED is a Hongkong-based investment holding company. The Company, along with its subsidiaries, is principally …See details»
China Resources Pharmaceutical Group - Crunchbase
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jan 10, 2023: Series B - China …See details»
China Resources Pharmaceutical Group - Contacts, Employees, …
CR Pharma engages in the research and development, manufacturing, distribution, and retail of pharmaceutical and healthcare products.See details»
China Resources Pharmaceutical : 2020 Sustainability Report
Apr 28, 2021 China Resources Pharmaceutical Group Limited (CR Pharmaceutical) (Stock Code: 3320.HK) is a leading integrated pharmaceutical company in China specializing in …See details»
China Resources Pharmaceutical Group Limited (3320.HK)
Find the latest China Resources Pharmaceutical Group Limited (3320.HK) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
China Resources Pharma in talks to buy controlling stake in …
May 16, 2018 China Resources Pharmaceutical Group Ltd said on Wednesday it is in talks with the provincial government of the southeast province of Jiangxi to acquire a controlling stake in …See details»
China Resources Pharma seeks up to $2 billion in Hong Kong IPO
Oct 11, 2016 China Resources Pharmaceutical Group is seeking to raise between HK$13 billion and HK$15.6 billion ($1.68 billion–$2.01 billion) from a Hong Kong initial public offering (IPO), …See details»
Everest Medicines signs MOU with China Resources …
Apr 7, 2022 CR Pharma, a subsidiary of State-owned China Resources (Holdings) Co Ltd, said through this cooperation, the two companies intend to work together in the development of …See details»
China Resources Pharma Restructures for Industry Growth
Nov 21, 2024 China Resources Pharmaceutical Group Ltd. is undergoing an internal reorganization aimed at enhancing its influence in the panax notoginseng industry by selling a …See details»
China Resources Pharmaceutical Group Limited (640.F)
Find the latest China Resources Pharmaceutical Group Limited (640.F) stock quote, history, news and other vital information to help you with your stock trading and investing.See details»
China Resources Gas Group Announces Board Composition
2 days ago China Resources Gas Group has announced its board of directors and their roles, highlighting the leadership of Chairman Yang Ping and the composition of various board …See details»